ATE116546T1 - Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis. - Google Patents

Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis.

Info

Publication number: ATE116546T1
Authority: AT; Austria
Prior art keywords: products; hepatitis; acid; colomic acid; colomic
Prior art date: 1991-03-07

Application number

AT92103908T

Other languages

English (en)

Inventor

Ryoichi Osawa

Isao Suda

Masaaki Numata

Mamoru Sugimoto

Kenkichi Tomita

Nobuyuki Kibushi

Takayuki Ishii

Naokazu Sugiyama

Makiko Kasano

Chome

Tae Yasunaga

Makoto Tanaka

Tomoya Ogawa

Mariko Ishii

Original Assignee

Kanto Ishi Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-07

Filing date

1992-03-06

Publication date

1995-01-15

1991-03-07 Priority claimed from JP6796691A external-priority patent/JPH04279526A/ja

1991-07-24 Priority claimed from JP20842791A external-priority patent/JPH0525050A/ja

1991-08-12 Priority claimed from JP22657891A external-priority patent/JPH0543468A/ja

1992-03-06 Application filed by Kanto Ishi Pharma Co Ltd filed Critical Kanto Ishi Pharma Co Ltd

1995-01-15 Application granted granted Critical

1995-01-15 Publication of ATE116546T1 publication Critical patent/ATE116546T1/de

Links

239000002253 acid Substances 0.000 title abstract 3
208000006454 hepatitis Diseases 0.000 title abstract 2
231100000283 hepatitis Toxicity 0.000 title abstract 2
230000007062 hydrolysis Effects 0.000 title abstract 2
238000006460 hydrolysis reaction Methods 0.000 title abstract 2
206010003246 arthritis Diseases 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
201000008383 nephritis Diseases 0.000 title 1
229940079593 drug Drugs 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 4
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
230000035605 chemotaxis Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000002955 immunomodulating agent Substances 0.000 abstract 1
229940121354 immunomodulator Drugs 0.000 abstract 1
230000002584 immunomodulator Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
208000017169 kidney disease Diseases 0.000 abstract 1
210000000440 neutrophil Anatomy 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT92103908T 1991-03-07 1992-03-06 Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis. ATE116546T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP6796691A JPH04279526A (ja)	1991-03-07	1991-03-07	腎疾患治療薬
JP20842791A JPH0525050A (ja)	1991-07-24	1991-07-24	肝炎治療薬
JP22657891A JPH0543468A (ja)	1991-08-12	1991-08-12	免疫調整薬

Publications (1)

Publication Number	Publication Date
ATE116546T1 true ATE116546T1 (de)	1995-01-15

Family

ID=27299603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92103908T ATE116546T1 (de)	1991-03-07	1992-03-06	Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis.

Country Status (8)

Country	Link
US (3)	US5516764A (de)
EP (1)	EP0502550B1 (de)
KR (1)	KR920017660A (de)
AT (1)	ATE116546T1 (de)
AU (1)	AU649110B2 (de)
CA (1)	CA2062370A1 (de)
DE (1)	DE69201066T2 (de)
DK (1)	DK0502550T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9904289D0 (sv) *	1999-11-26	1999-11-26	Niklas Arnberg	Method and camposition for the treatment of adenovairal ocular infections
EP2147679B1 (de)	2001-07-25	2014-06-25	Raptor Pharmaceutical, Inc.	Zusammensetzungen für den Blut-Hirn-Schrankentransport
EP2392258B1 (de)	2005-04-28	2014-10-08	Proteus Digital Health, Inc.	Pharma-Informatiksystem
CN101594878A (zh)	2006-09-18	2009-12-02	雷普特药品公司	通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
PL3395372T3 (pl)	2009-02-20	2022-07-25	EnhanX Biopharm Inc.	Układ do dostarczania leków na bazie glutationu
CN102458374A (zh)	2009-05-06	2012-05-16	实验室护肤股份有限公司	包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates
EP2783691A1 (de) *	2013-03-28	2014-10-01	Rheinische Friedrich-Wilhelms-Universität Bonn	Polysialinsäuren und Verwendung zur Behandlung neurodegenerativer und neuroinflammatorischer Erkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0109688A3 (de) *	1982-11-23	1986-12-03	The Wellcome Foundation Limited	Komplexe, Verfahren zu deren Herstellung und diese Komplexe enthaltende Zusammensetzungen
JPH0720878B2 (ja) *	1983-11-21	1995-03-08	ザウエルカムフアウンデ−シヨンリミテツド	改善された複合体、それらの製造法および該複合体を含有する製剤
JPH07114695B2 (ja) *	1986-06-16	1995-12-13	丸金醤油株式会社	ノイラミニダ−ゼの製造法
JPH01299294A (ja) *	1988-05-24	1989-12-04	Mect Corp	４，８−アンハイドロ−ｎ−アセチルノイラミン酸誘導体
JPH0219393A (ja) *	1988-07-08	1990-01-23	Higeta Shoyu Kk	Ｎ‐アセチルガラクトサミノオリゴ糖及びその製造方法
JP2975632B2 (ja) *	1990-03-30	1999-11-10	生化学工業株式会社	グリコサミノグリカン修飾プロテイン

1992
- 1992-03-06 AT AT92103908T patent/ATE116546T1/de not_active IP Right Cessation
- 1992-03-06 AU AU11494/92A patent/AU649110B2/en not_active Ceased
- 1992-03-06 CA CA002062370A patent/CA2062370A1/en not_active Abandoned
- 1992-03-06 DK DK92103908.7T patent/DK0502550T3/da active
- 1992-03-06 EP EP92103908A patent/EP0502550B1/de not_active Expired - Lifetime
- 1992-03-06 DE DE69201066T patent/DE69201066T2/de not_active Expired - Fee Related
- 1992-03-07 KR KR1019920003815A patent/KR920017660A/ko not_active Abandoned
1994
- 1994-03-28 US US08/219,236 patent/US5516764A/en not_active Expired - Fee Related
1995
- 1995-05-25 US US08/450,930 patent/US5763420A/en not_active Expired - Fee Related
- 1995-05-25 US US08/450,699 patent/US5668115A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU1149492A (en)	1992-09-10
DE69201066D1 (de)	1995-02-16
US5763420A (en)	1998-06-09
KR920017660A (ko)	1992-10-21
EP0502550A1 (de)	1992-09-09
DK0502550T3 (da)	1995-05-29
US5516764A (en)	1996-05-14
US5668115A (en)	1997-09-16
CA2062370A1 (en)	1992-09-08
DE69201066T2 (de)	1995-05-11
EP0502550B1 (de)	1995-01-04
AU649110B2 (en)	1994-05-12

Similar Documents

Publication	Publication Date	Title
ATE120644T1 (de)	1995-04-15	Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
ATE213733T1 (de)	2002-03-15	Zwischenprodukte zur herstellung retroviraler proteasehemmenden verbindungen
ATE25974T1 (de)	1987-04-15	Acyl-substituierte derivate von 1,2,3,4tetrahydroisochinolin-3-carboxysaeuren, ihre salze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung.
FI112471B (fi)	2003-12-15	Menetelmä uusien terapeuttisesti käyttökelpoisten hydroksietyyliaminosulfoniamidien valmistamiseksi
EP0624595A3 (de)	1995-06-28	nor-Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
SE8704298D0 (sv)	1987-11-03	Compounds for use in therapy
CA2120942A1 (en)	1994-03-03	Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation
ATE181080T1 (de)	1999-06-15	Hiv-proteaseinhibitoren
FI953139A0 (fi)	1995-06-22	Atovakonia käsittäviä farmaseuttisia koostumuksia
EP0610048A3 (de)	1995-06-21	Verfahren zur Herstellung von Phenylgruppe enthaltende optisch-aktiven Alpha-Hydroxycarbonsäuren.
DK0587088T3 (da)	1996-09-23	Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
ATE123944T1 (de)	1995-07-15	Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
ATE116546T1 (de)	1995-01-15	Colominsäure und produkte einer teilweisen hydrolyse von colominsäure zur herstellung von arzneimitteln zur behandlung von hepatitis, nephritis und arthritis.
ITMI911555A1 (it)	1992-12-06	Processo per la produzione di soluzioni acquose di acido lattico purificate a partire da brodi di fermentazione.
KR0148213B1 (en)	1998-08-17	Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE69207479D1 (de)	1996-02-22	Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
ATE135573T1 (de)	1996-04-15	Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
FR2692263B1 (fr)	1994-09-23	Procédé de préparation d'esters cycliques d'acides-alpha-hydroxycarboxyliques.
FI97136B (fi)	1996-07-15	Menetelmä terapeuttisesti käyttökelpoisten 4-metoksi-10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/-undek-2-eeni-2-karboksyylihappojen asyylioksialkyyliestereiden valmistamiseksi
ATE380789T1 (de)	2007-12-15	Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie
FR2610633B1 (fr)	1992-09-18	Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament
ATE183088T1 (de)	1999-08-15	Arzneimittel zur behandlung von hauterkrankungen
DE69531554D1 (de)	2003-09-25	Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69610045D1 (de)	2000-10-05	Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen

Legal Events

Date	Code	Title	Description
1995-08-15	UEP	Publication of translation of european patent specification
1998-12-15	REN	Ceased due to non-payment of the annual fee